Rapid imaging of experimental infection with technetium-99m-DTPA after anti-DTPA monoclonal antibody priming

Journal of Nuclear Medicine

Volumn 38, Issue 6, 1997, Pages 901-906

  Kranenborg, Marion H G C ^a   Oyen, Wim J G ^a   Corstens, Frans H M ^a   Oosterwijk, Egbert ^a   Van Der Meer, Jos W M ^a   Boerman, Otto C ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Infection imaging; Monoclonal antibody priming; Pretargeting protocols; Technetium 99m DTPA

Indexed keywords

AVIDIN; BOVINE SERUM ALBUMIN; IMMUNOGLOBULIN G; MACROSALB TC 99M; MONOCLONAL ANTIBODY; PENTETATE TECHNETIUM TC 99M;

ABSCESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOSE RESPONSE; DRUG DISTRIBUTION; HUMAN; INFECTION; MALE; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

ABSCESS; ANIMALS; ANTIBODIES, MONOCLONAL; CATTLE; GOATS; HUMANS; MALE; RADIOIMMUNODETECTION; RATS; RATS, WISTAR; SERUM ALBUMIN, BOVINE; STAPHYLOCOCCAL INFECTIONS; TECHNETIUM TC 99M PENTETATE; TISSUE DISTRIBUTION;

EID: 0030940371     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Rubin RH, Fischman AJ, Needleman M, et al. Radiolabeled, nonspecific, polyclonal human immunoglobulin in the detection of focal inflammation by scintigraphy: comparison with gallium-67 citrate and technetium-99m-labeled albumin. J Nucl Med 1989;30:385-389.
2. Oyen WJG, Claessens RAMJ, van der Meer JWM, Rubin RH, Strauss HW, Corstens FHM. Indium-111-labeled human nonspecific immunoglobulin G: a new radiopharmaceutical for imaging infectious and inflammatory foci. Clin Infect Dis 1992;14:1110-1118.
3. Oyen WJG, Claessens RAMJ, van der Meer JWM, Corstens FHM. Biodistribution and kinetics of radiolabeled proteins in rats with focal infection. J Nucl Med 1992;33:388-394.
4. Morrel EM, Tompkins RG, Fischman AJ, et al. Autoradiographic method for quantitation of radiolabeled proteins in tissues using indium-111. J Nucl Med 1989;30:1538-1545.
5. Fischman AJ, Babich JW, Rubin RH. Infection imaging with technetium-99m-labeled chemotactic peptide analogs. Semin Nucl Med 1994;24:154-168.
6. Paganelli G, Magnani P, Zito F, et al. Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients. Cancer Res 1991;51:5960-5966.
7. Hnatowich DJ, Fritz B, Virzi F, Mardirossian G, Rusckowski M. Improved tumor localization with (strept)avidin and labeled biotin as a substitute for antibody. Nucl Med Biol 1993;20:189-195.
8. Rusckowski M, Fritz B, Hnatowich DJ. Localization of infection using streptavidin and biotin: an alternative to nonspecific polyclonal immunoglobulin. J Nucl Med 1992;33:1810-1815.
9. Goodwin DA, Meares CF, McCall MJ, McTigue M, Chaovapong W. Pretargeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens. J Nucl Med 1988;29:226-234.
10. Le Doussal JM, Martin M, Gautherot E, Delaage M, Barbet J. In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate. J Nucl Med 1989;30:1358-1366.
11. Le Doussal JM, Gruaz-Guyon A, Martin M, et al. Targeting of indium-labeled bivalent hapten to human melanoma mediated bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice. Cancer Res 1990;50:3445-3452.
12. Stickney DR, Anderson LD, Slater JB, et al. Bifunctional antibody: a binary radiopharmaceutical delivery system for imaging colorectal carcinoma. Cancer Res 1991;51:6650-6655.
13. Kranenborg MHGC, Boerman OC, Oosterwijk-Wakka JC, de Weijert MCA, Corstens FHM, Oosterwijk E. Development and characterization of anti-renal-cell carcinoma x anti-DTPA bispecific monoclonal antibodies for two-phase targeting of renal-cell carcinoma. Cancer Res 1995;55:5864S-5867S.
14. Oosterwijk E, Ruiter DJ, Hoedemaeker PJ, et al. Monoclonal antibody G250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int J Cancer 1986;38:489-494.
15. Fraker PJ, Speck JC Jr. Protein and cell membrane iodinations with a sparingly soluble chloramide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun 1978;80:849-857.
16. Green NM. A spectrophotometric assay for avidin and biotin based on binding of dyes by avidin. Biochem J 1965;94:23c-24c.
17. Hnatowich DJ, Childs RL, Lanteigne D, Najafi A. The preparation of DTPA-coupled antibodies radiolabeled with metallic radionuclides: an improved method. J Immunol Methods 1983;65:147-157.
18. 2 fragments of an anti-tumor antibody. Br J Cancer 1995;71:18-24.
19. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1956;28:350-356.
20. Corstens FHM, van der Meer JWM. Chemotactic peptides: new locomotion for imaging of infection? J Nucl Med 1991;32:491-494.
21. Yao Z, Zhang M, Kobayashi H, et al. Improved targeting of radiolabeled streptavidin in tumors pretargeted with biotinylated monoclonal antibodies through an avidin chase. J Nucl Med 1995;36:837-841.
22. Kobayashi H, Sakahara H, Endo K, et al. Comparison of the chase effects of avidin, streptavidin, neutravidin and avidin-ferritin on a radiolabeled biotinylated anti-tumor monoclonal antibody. Jpn J Cancer Res 1995;86:310-314.
23. Sinitsyn VV, Mamontova AG, Checkneva YY, Shnyra AA, Domogatsky SP. Rapid blood clearance of biotinylated IgG after infusion of avidin. J Nucl Med 1989;30:66-69.
24. Sharkey RM, Primus FJ, Goldenberg DM. Second antibody clearance of radiolabeled antibody for cancer radioimmunodetection. Proc Natl Acad Sci USA 1984;81:2843-2846.
25. Sharkey RM, Mabus J, Goldenberg DM. Factors influencing anti-antibody enhancement of tumor targeting with antibodies in hamsters with human colonie tumor xenografts. Cancer Res 1988;48:2005-2009.
26. Stockert RJ. The asialoglycoprotein receptor: relationships between structure, function and expression. Physiol Rev 1995;75:591-609.